USPTO serial 50189808
BGBX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with BGBX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
New York, NY, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lori P. Hager
Lori P. Hager Kyberia Legal88 S Finley Avenue 2nd Fl. Suite ABasking Ridge, NJ 07920United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advertising agencies specializing in marketing strategies to promote businesses; Advertising and marketing consultancy; Advertising and publicity services, namely, promoting the goods, services, brand identity and commercial information and news of third parties through digital technology, video and live events; Advertising consultation; Advertising services in the field of pharmaceuticals; Advertising services, namely, creating corporate and brand identity for others; Advertising services, namely, promoting and marketing the goods and services of others in the field of pharmaceuticals via print and electronic media; Brand concept and brand development services for corporate clients; Business consultation in the field of pharmaceuticals; Concept and brand development services for corporate clients; Conducting market surveys; Digital advertising services; Market analysis and research services; Marketing consultation in the field of pharmaceuticals; Marketing consulting; Marketing plan development; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others; Business consulting services relating to the integration of the areas of business process technology, organizational learning, change management, and operational sustainability; Computerized database management; Management and compilation of computerised databases; Business management consultation in the field of pharmaceuticals; Business advisory services in the field of pharmaceuticals; Business strategic planning services in the field of marketing services and data analysis, in the pharmaceutical industry; Business assistance, management and information services; Information, advisory and consultancy services relating to business and management or business administration, including such services provided on line or via the internet; Consultancy and advisory services in the field of business strategy; Business management consulting and advisory services for the pharmaceutical industry; Business consulting services in the field of business management, workflow and quality in the pharmaceutical industry; Business administration services in the field of pharmaceuticals; Data processing services in the field of pharmaceuticals; Marketing services, namely, consumer marketing research; Marketing forecasting; Marketing services rendered using artificial intelligence (AI); Providing business management information in connection with consulting and advisory services in the field of strategic planning; Business advisory services in the field of pharmaceuticals, namely providing descriptive and predictive analytics; Business advisory services in the field of pharmaceuticals, namely providing formulation of best practices for the pharmaceuticals industry; Preparation of business reports; Business management consultancy services | ACTIVE | Jun 1, 2026 |
| 036 | Strategic corporate financial advisory services; Financial advisory services; Information, advisory, consultancy and financial research services relating to finance and investments; Financial advisory and consultancy services, namely, strategic corporate financial advisory, and investments advisory services; Financial advisory and consultancy services, namely, services related to financial profiles; Financial advisory and consultancy services, namely, financial revenue forecasts | ACTIVE | Jun 1, 2026 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 29, 2026 | NWAP | NEW APPLICATION ENTERED | — |